Ryufin

Immsi S.p.A.

Italy · IT0001413837 · reports in EUR · Europe

The answers

From the annual report for the year to Dec 31, 2025. Each line says what it is based on.

Is it growing?To watch
Revenue −8.9% in the year to Dec 31, 2025, on the year before.
Is it a good business?To watch
It earned 0.1% on its shareholders' equity in the year to Dec 31, 2025.
Is it safe?To watch
Equity is 16% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2025, consolidated, in EUR.

€1.6B

revenue

6.3%

operating margin

€98,000

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2022Dec 2023Dec 2024Dec 2025
Revenue€2.1B€2.0B€1.7B€1.6B
Operating profit€144M€161M€129M€100M
Net profit to shareholders€27M€19M€6M€98,000
Earnings per share€0.08€0.06n/an/a
Cash from operations€220M€149M€114M€144M
Capital spending€66M€68M€90M€77M
Cash€264M€196M€159M€156M
Total assets€2.4B€2.3B€2.3B€2.2B
Equity€409M€395M€385M€351M

What they do

In the company's own words, from the annual report.

Le principali attività della Società e delle sue controllate (il “Gruppo Immsi” e il “Gruppo”), l’informativa sui fatti di rilievo intervenuti dopo la chiusura dell’esercizio e sulla prevedibile evoluzione della gestione sono descritti nella Relazione sulla Gestione degli Amministratori.

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.